| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in amyotrophic lateral sclerosis research in 2022
|
de Carvalho, Mamede
|
|
|
22 |
1 |
p. 21-22
|
artikel
|
| 2 |
Ageing and multiple sclerosis
|
Graves, Jennifer S
|
|
|
22 |
1 |
p. 66-77
|
artikel
|
| 3 |
Bastiaan Bloem: power against Parkinson's disease
|
Burton, Adrian
|
|
|
22 |
1 |
p. 30
|
artikel
|
| 4 |
Clinical trials in stroke in 2022: new answers and questions
|
Goyal, Mayank
|
|
|
22 |
1 |
p. 9-10
|
artikel
|
| 5 |
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study
|
Boerwinkle, Anna H
|
|
|
22 |
1 |
p. 55-65
|
artikel
|
| 6 |
Credulity of exploratory trials for cerebral cavernous malformations
|
Shenkar, Robert
|
|
|
22 |
1 |
p. 2-3
|
artikel
|
| 7 |
Dementia research in 2022: advancing steadily on reflection
|
Zhang, Ya-Ru
|
|
|
22 |
1 |
p. 10-12
|
artikel
|
| 8 |
Early atrial fibrillation rhythm control after stroke
|
Calvert, Peter
|
|
|
22 |
1 |
p. 3-4
|
artikel
|
| 9 |
Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial
|
Jensen, Märit
|
|
|
22 |
1 |
p. 45-54
|
artikel
|
| 10 |
Epilepsy research in 2022: clinical advances
|
Blank, Leah J
|
|
|
22 |
1 |
p. 15-17
|
artikel
|
| 11 |
Headache research in 2022: advances and remaining challenges
|
Reuter, Uwe
|
|
|
22 |
1 |
p. 14-15
|
artikel
|
| 12 |
Highlights in traumatic brain injury research in 2022
|
Robba, Chiara
|
|
|
22 |
1 |
p. 12-13
|
artikel
|
| 13 |
Ideas that come at night: on sleep research in 2022
|
Arnulf, Isabelle
|
|
|
22 |
1 |
p. 23-24
|
artikel
|
| 14 |
Increasing diversity in dementia research
|
The Lancet Neurology,
|
|
|
22 |
1 |
p. 1
|
artikel
|
| 15 |
Lessons from Down syndrome and autosomal dominant Alzheimer's disease
|
Fortea, Juan
|
|
|
22 |
1 |
p. 5-6
|
artikel
|
| 16 |
Märit Jensen
|
|
|
|
22 |
1 |
p. 31
|
artikel
|
| 17 |
Multiple sclerosis in 2022: old players, new insights
|
Chitnis, Tanuja
|
|
|
22 |
1 |
p. 19-21
|
artikel
|
| 18 |
Multiple sclerosis progression: time for a new mechanism-driven framework
|
Kuhlmann, Tanja
|
|
|
22 |
1 |
p. 78-88
|
artikel
|
| 19 |
Neurology behind the lens
|
Araújo, Rui
|
|
|
22 |
1 |
p. 34
|
artikel
|
| 20 |
Neuroscience highlights in 2022: cytoskeletal transport
|
Sleigh, James N
|
|
|
22 |
1 |
p. 25-27
|
artikel
|
| 21 |
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment
|
Bennett, Jeffrey L
|
|
|
22 |
1 |
p. 89-100
|
artikel
|
| 22 |
Pain research in 2022: nociceptors and central sensitisation
|
Treede, Rolf-Detlef
|
|
|
22 |
1 |
p. 24-25
|
artikel
|
| 23 |
Research in movement disorders in 2022: a new era of biomarker and treatment development
|
Klein, Christine
|
|
|
22 |
1 |
p. 17-19
|
artikel
|
| 24 |
Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
|
Lanfranconi, Silvia
|
|
|
22 |
1 |
p. 35-44
|
artikel
|
| 25 |
Studying sex and gender in neurological disease
|
Al-Hassany, Linda
|
|
|
22 |
1 |
p. 32-33
|
artikel
|
| 26 |
The advent of stroke units
|
Drouin, Emmanuel
|
|
|
22 |
1 |
p. 31
|
artikel
|
| 27 |
The African Dementia Consortium
|
Akinyemi, Rufus O
|
|
|
22 |
1 |
p. 28-29
|
artikel
|
| 28 |
The shortage of thrombolytics for stroke: a call for action
|
Pensato, Umberto
|
|
|
22 |
1 |
p. 28
|
artikel
|
| 29 |
Time to reconsider the classification of multiple sclerosis
|
Yamamura, Takashi
|
|
|
22 |
1 |
p. 6-8
|
artikel
|
Tijdschrift beschrijving